Company Filing History:
Years Active: 2021-2025
Title: Matthew Siefert: Innovator in Nucleic Acid Transfer
Introduction
Matthew Siefert is a notable inventor based in Cincinnati, OH (US). He has made significant contributions to the field of gene therapy through his innovative work on nucleic acid delivery systems. With a total of 2 patents, Siefert's research focuses on enhancing the methods of nucleic acid transfer, which is crucial for effective gene therapy techniques.
Latest Patents
Siefert's latest patents include compositions and methods for nucleic acid transfer. These patents disclose methods for the enhancement of nucleic acid delivery systems. The methods may employ treatment with a compound and/or an RNAi molecule in combination with a nucleic acid to improve nucleic acid uptake into a cell. In particular, the disclosed methods may be useful for improved gene therapy techniques.
Career Highlights
Matthew Siefert is currently associated with the Children's Hospital Medical Center, where he continues to advance his research in the field of gene therapy. His work is instrumental in developing more effective treatments for various genetic disorders.
Collaborations
Siefert has collaborated with notable colleagues, including Assem G Ziady and Songbai Lin, who share his commitment to advancing medical science through innovative research.
Conclusion
Matthew Siefert's contributions to nucleic acid transfer and gene therapy highlight his role as a key innovator in the medical field. His ongoing research promises to enhance the effectiveness of gene therapy techniques, paving the way for future advancements in treatment options.